Viewing Study NCT00068666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT00068666
Status: TERMINATED
Last Update Posted: 2016-12-15
First Post: 2003-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: N0274
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View